Haldeman Laboratory for Molecular Diagnostics and Therapeutics

The Haldeman Laboratory for Molecular and Cellular Neurobiology is looking at novel techniques to diagnose and treat Alzheimer’s disease.

The lab has been working on the following:

  • Developing novel techniques to diagnose Alzheimer's disease as well as preclinical testing of new compounds for Alzheimer's treatment.
  • Creating a new protein assay so that in the future a simple blook test could evaluate people at risk of developing Alzheimer's.
  • Testing the potential of an anti-cancer drug to reduce brain inflammation and the number of amyloid plaque deposits in Alzheimer's-like mice.

The lab in conjunction with the Cleo Roberts Center for Clinical Research is conducting a cutting-edge clinical trial aimed at slowing the progression of Alzheimer's disease.

This research will not only advance the understanding of of Alzheimer’s disease, but also will provide alternative therapeutic targets for Alzheimer’s treatments.